ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Sigma-Aldrich’s SAFC custom manufacturing business will collaborate with Baxter’s BioPharma Solutions unit to produce antibody-drug conjugates. SAFC will contribute capability for manufacturing drug linkers and conducting conjugations, while Baxter will provide sterile drug product filling and finishing services. Together, the companies hope to provide customers with end-to-end contract manufacturing in which a bulk drug substance conjugated by SAFC is transferred to Baxter for final steps including filling, regulatory testing, and packaging.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter